Chemical synthesis and molecular docking study of new thiazole, thiophene, and thieno[2,3-d]pyrimidine derivatives as potential antiproliferative and antimicrobial agents

[1]  A. Amr,et al.  New Benzimidazole-, 1,2,4-Triazole-, and 1,3,5-Triazine-Based Derivatives as Potential EGFRWT and EGFRT790M Inhibitors: Microwave-Assisted Synthesis, Anticancer Evaluation, and Molecular Docking Study , 2022, ACS omega.

[2]  A. Amr,et al.  Design, synthesis, anticancer evaluation and molecular docking study of novel 2,4-dichlorophenoxymethyl-based derivatives linked to nitrogenous heterocyclic ring systems as potential CDK-2 inhibitors , 2022 .

[3]  M. Gad-Elkareem,et al.  Synthesis and biological evaluation of new derivatives of thieno-thiazole and dihydrothiazolo-thiazole scaffolds integrated with a pyrazoline nucleus as anticancer and multi-targeting kinase inhibitors , 2021, RSC advances.

[4]  V. Georgiyants,et al.  Design, Synthesis and In Vitro Antimicrobial Activity of 6-(1H-Benzimidazol-2-yl)-3,5-dimethyl-4-oxo-2-thio-3,4-dihydrothieno[2,3-d]pyrimidines , 2021, Scientia Pharmaceutica.

[5]  G. Moustafa,et al.  Synthesis, anticancer evaluation and molecular docking of new benzothiazole scaffolds targeting FGFR-1. , 2021, Bioorganic chemistry.

[6]  C. B. Mishra,et al.  Emerging Importance of Tyrosine Kinase Inhibitors against Cancer: Quo Vadis to Cure? , 2021, International journal of molecular sciences.

[7]  E. S. Nossier,et al.  Synthesis, anticancer activity and molecular docking of new triazolo[4,5-d]pyrimidines based thienopyrimidine system and their derived N-glycosides and thioglycosides , 2021, Nucleosides, nucleotides & nucleic acids.

[8]  K. Dawood,et al.  Novel Bis-Thiazole Derivatives: Synthesis and Potential Cytotoxic Activity Through Apoptosis With Molecular Docking Approaches , 2021, Frontiers in Chemistry.

[9]  S. Gaonkar,et al.  1,3,4-Oxadiazole-containing hybrids as potential anticancer agents: Recent developments, mechanism of action and structure-activity relationships , 2021, Journal of Saudi Chemical Society.

[10]  G. Moustafa,et al.  Synthesis, Characterization, In Vitro Anticancer Potentiality, and Antimicrobial Activities of Novel Peptide–Glycyrrhetinic-Acid-Based Derivatives , 2021, Molecules.

[11]  S. Li,et al.  Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist. , 2021, Journal of medicinal chemistry.

[12]  M. Anwar,et al.  New pyrimidine and pyrazole-based compounds as potential EGFR inhibitors: Synthesis, anticancer, antimicrobial evaluation and computational studies. , 2021, Bioorganic chemistry.

[13]  Y. Şirin,et al.  Recent studies of nitrogen containing heterocyclic compounds as novel antiviral agents: A review. , 2021, Bioorganic chemistry.

[14]  G. Moustafa,et al.  Novel Benzothiazole Hybrids Targeting EGFR: Design, Synthesis, Biological Evaluation and Molecular Docking Studies , 2021 .

[15]  Ashraf S. Hassan,et al.  Design, Synthesis, Anticancer Evaluation, Enzymatic Assays, and a Molecular Modeling Study of Novel Pyrazole–Indole Hybrids , 2021, ACS omega.

[16]  M. Khedr,et al.  Discovery of New Coumarin-Based Lead with Potential Anticancer, CDK4 Inhibition and Selective Radiotheranostic Effect: Synthesis, 2D & 3D QSAR, Molecular Dynamics, In Vitro Cytotoxicity, Radioiodination, and Biodistribution Studies , 2021, Molecules.

[17]  A. El-Galil E. Amr,et al.  Design, synthesis and molecular docking of new pyrazole-thiazolidinones as potent anti-inflammatory and analgesic agents with TNF-α inhibitory activity. , 2021, Bioorganic chemistry.

[18]  Aboubakr Haredi Abdelmonsef,et al.  Thiazole-Based Thiosemicarbazones: Synthesis, Cytotoxicity Evaluation and Molecular Docking Study , 2021, Drug design, development and therapy.

[19]  Anca-Maria Borcea,et al.  An Overview of the Synthesis and Antimicrobial, Antiprotozoal, and Antitumor Activity of Thiazole and Bisthiazole Derivatives , 2021, Molecules.

[20]  E. S. Nossier,et al.  Click chemistry based synthesis, cytotoxic activity and molecular docking of novel triazole-thienopyrimidine hybrid glycosides targeting EGFR , 2021, Journal of enzyme inhibition and medicinal chemistry.

[21]  R. Esmaeili,et al.  Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis. , 2021, European journal of medicinal chemistry.

[22]  K. Mahmoud,et al.  Thiopyrimidine‐5‐carbonitrile Derivatives as VEGFR‐2 Inhibitors: Synthesis, Anticancer Evaluation, Molecular Docking, ADME Predictions and QSAR Studies , 2020, ChemistrySelect.

[23]  Ting Guo,et al.  Recent Advances in the Discovery of Multitargeted Tyrosine Kinase Inhibitors as Anticancer Agents , 2020, ChemMedChem.

[24]  Eman A. Karam,et al.  Synthesis and Biological Evaluation of New Pyridothienopyrimidine Derivatives as Antibacterial Agents and Escherichia coli Topoisomerase II Inhibitors , 2020, Antibiotics.

[25]  Liying Yu,et al.  Design, synthesis and antitumor activity of novel thiophene-pyrimidine derivatives as EGFR inhibitors overcoming T790M and L858R/T790M mutations. , 2020, European journal of medicinal chemistry.

[26]  Archna,et al.  Thiophene-based derivatives as anticancer agents: An overview on decade's work. , 2020, Bioorganic chemistry.

[27]  E. A. Elsayed,et al.  Synthesis, Antimicrobial Activity and Molecular Docking of Novel Thiourea Derivatives Tagged with Thiadiazole, Imidazole and Triazine Moieties as Potential DNA Gyrase and Topoisomerase IV Inhibitors , 2020, Molecules.

[28]  Mamdouh M. Ali,et al.  Synthesis and molecular docking study of new pyrazole derivatives as potent anti-breast cancer agents targeting VEGFR-2 kinase. , 2020, Bioorganic chemistry.

[29]  E. A. Elsayed,et al.  Chiral Pyridine-3,5-bis- (L-phenylalaninyl-L-leucinyl) Schiff Base Peptides as Potential Anticancer Agents: Design, Synthesis, and Molecular Docking Studies Targeting Lactate Dehydrogenase-A , 2020, Molecules.

[30]  E. A. Elsayed,et al.  Novel heterocyclic hybrids of pyrazole targeting dihydrofolate reductase: design, biological evaluation and in silico studies , 2020, Journal of enzyme inhibition and medicinal chemistry.

[31]  Eman A. Karam,et al.  Synthesis, Docking Studies, and In Vitro Evaluation of Some Novel Thienopyridines and Fused Thienopyridine–Quinolines as Antibacterial Agents and DNA Gyrase Inhibitors , 2019, Molecules.

[32]  E. S. Nossier,et al.  Molecular Docking Study of Newly Synthesized Thiopyrimidines as Antimicrobial Agents Targeting DNA Gyrase Enzyme , 2019, Journal of Heterocyclic Chemistry.

[33]  C. Oh,et al.  Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances. , 2019, Bioorganic & medicinal chemistry.

[34]  P. Verma,et al.  Therapeutic importance of synthetic thiophene , 2018, Chemistry Central Journal.

[35]  Ali Ramazani and Zahra Hosseinzadeh.  Anti-cancer Nitrogen-Containing Heterocyclic Compounds , 2018, Current Organic Chemistry.

[36]  A. Abdelhamid,et al.  Efficient Synthesis of New Benzofuran-based Thiazoles and Investigation of their Cytotoxic Activity Against Human Breast Carcinoma Cell Lines: Efficient Synthesis of New Benzofuran-based Thiazoles and Investigation of their Cytotoxic Activity Against Human Breast Carcinoma Cell Lines , 2018 .

[37]  Amareshwar T. K. Singh,et al.  Apoptosis: A Target for Anticancer Therapy , 2018, International journal of molecular sciences.

[38]  M. Anwar,et al.  Development of Promising Thiopyrimidine-Based Anti-cancer and Antimicrobial Agents: Synthesis and QSAR Analysis. , 2018, Mini reviews in medicinal chemistry.

[39]  S. Ceruti,et al.  Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases , 2017, Front. Pharmacol..

[40]  Rangappa S. Keri,et al.  An overview of benzo[b]thiophene-based medicinal chemistry. , 2017, European journal of medicinal chemistry.

[41]  S. El-Hallouty,et al.  SYNTHESIS, ANTICANCER EVALUATION AND MOLECULAR MODELING OF SOME SUBSTITUTED THIAZOLIDINONYL AND THIAZOLYL PYRAZOLE DERIVATIVES , 2015 .

[42]  A. Shafiee,et al.  Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery. , 2015, European journal of medicinal chemistry.

[43]  Ki Duk Park,et al.  Synthesis of Novel Dihydropyridothienopyrimidin-4,9-dione Derivatives , 2015, Molecules.

[44]  J. Manfredi,et al.  p53 Promotes Cell Survival due to the Reversibility of Its Cell-Cycle Checkpoints , 2014, Molecular Cancer Research.

[45]  V. Gandhi,et al.  Targeting the apoptosis pathway in hematologic malignancies , 2014, Leukemia & lymphoma.

[46]  T. Taniguchi,et al.  Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold. , 2011, Journal of medicinal chemistry.

[47]  R. Onur,et al.  The effects of melatonin and the antioxidant defence system on apoptosis regulator proteins (Bax and Bcl-2) in experimentally induced varicocele , 2004, Urological Research.

[48]  S. Fox,et al.  Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up. , 1996, Human pathology.

[49]  C. Rodriguez,et al.  An antibiotic assay by the agar well diffusion method , 1990 .